Kinase du lymphome anaplasique (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kinase du lymphome anaplasique" in French language version.

refsWebsite

Global rank French rank

4^th place

12^th place

1,626^th place

2,018^th place

2^nd place

3^rd place

57^th place

4^th place

2,769^th place

931^st place

1aacrjournals.org

8,869^th place

4,895^th place

2,374^th place

298^th place

1,248^th place

778^th place

aacrjournals.org

clincancerres.aacrjournals.org

Rodig SJ, Mino-Kenudson M, Dacic S et al. Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population, Clin Cancer Res, 2009;15:5216-5223

acs.org

pubs.acs.org

Marsilje TH, Pei W, Chen B et al. Synthesis, structure-activity relationships and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor LDK378 currently in phase 1 and 2 clinical trials, J Med Chem, 2013;56:5675-5690

doi.org

dx.doi.org

Mark A. Lemmon et Joseph Schlessinger, « Cell Signaling by Receptor Tyrosine Kinases », Cell, vol. 141, n^o 7,‎ juin 2010, p. 1117–1134 (ISSN 0092-8674, PMID 20602996, PMCID PMC2914105, DOI 10.1016/j.cell.2010.06.011, lire en ligne, consulté le 31 mai 2024)

doi.org

Mark A. Lemmon et Joseph Schlessinger, « Cell Signaling by Receptor Tyrosine Kinases », Cell, vol. 141, n^o 7,‎ juin 2010, p. 1117–1134 (ISSN 0092-8674, PMID 20602996, PMCID PMC2914105, DOI 10.1016/j.cell.2010.06.011, lire en ligne, consulté le 31 mai 2024)

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000171094 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000055471 - Ensembl, May 2017

issn.org

portal.issn.org

Mark A. Lemmon et Joseph Schlessinger, « Cell Signaling by Receptor Tyrosine Kinases », Cell, vol. 141, n^o 7,‎ juin 2010, p. 1117–1134 (ISSN 0092-8674, PMID 20602996, PMCID PMC2914105, DOI 10.1016/j.cell.2010.06.011, lire en ligne, consulté le 31 mai 2024)

lww.com

journals.lww.com

Inamura K, Takeuchi K, Togashi Y et al. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers, J Thorac Oncol, 2008;3:13-17

nejm.org

Shaw AT, Kim DW, Nakagawa K et al. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer, N Engl J Med, 2013;368:2385-2394

nih.gov

ncbi.nlm.nih.gov

« Publications PubMed pour l'Homme », sur National Center for Biotechnology Information, U.S. National Library of Medicine
« Publications PubMed pour la Souris », sur National Center for Biotechnology Information, U.S. National Library of Medicine
Mark A. Lemmon et Joseph Schlessinger, « Cell Signaling by Receptor Tyrosine Kinases », Cell, vol. 141, n^o 7,‎ juin 2010, p. 1117–1134 (ISSN 0092-8674, PMID 20602996, PMCID PMC2914105, DOI 10.1016/j.cell.2010.06.011, lire en ligne, consulté le 31 mai 2024)